Search for Clinical Trial Results

Sponsored By

Lymphoma, B-Cell, Marginal Zone - 24 Studies Found

Status Study
Recruiting Study Name: Marginal Zone Lymphoma Cohort in Korea
Condition: Lymphoma, B-Cell, Marginal Zone
Date: 2016-04-04
Interventions: Other: Rituximab Cohort observation study
Recruiting Study Name: Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Condition: Lymphoma, B-Cell, Marginal Zone
Date: 2017-03-23
Interventions: Drug: Ibrutinib 560mg administered orally once daily.
Completed Study Name: Endomicroscopy and Gastric MALT-lymphoma
Condition: MALT-lymphoma
Date: 2012-01-08
Interventions:
  • Procedure: Confocal laser endomicroscopy

Recruiting Study Name: Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Condition: Marginal Zone B-cell Lymphoma
Date: 2015-04-05
Interventions: Drug: bendamustine plus rituximab Bendamustine 90mg/m2 IV on days 1-2 up to 6th cycle Rituximab 375mg/m2
Active, not recruiting Study Name: Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma
Condition: MALT Lymphoma
Date: 2013-03-06
Interventions:
  • Drug: Chlorambucil
  • Drug: Rituximab i.v.
Recruiting Study Name: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma
Condition: Mucosa-Associated Lymphoid Tissue Lymphoma
Date: 2016-12-01
Not yet recruiting Study Name: A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
Condition:
  • Relapsed Marginal Zone Lymphoma
  • Refractory MALT Lymphoma
    Date: 2005-09-13
    Interventions: Other: Omeprazole, Amoxicillin, Clarithromycin Omeprazole20 mg,Clarithromycin500 mg b.i.d.,Day 1-14 plus
Completed Study Name: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Condition: Marginal Zone Lymphoma
Date: 2007-03-27
Interventions:
  • Drug: Rituximab IV Infusion of
Active, not recruiting Study Name: Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
Condition: Non-gastric Marginal Zone Lymphoma
Date: 2006-09-14
Interventions: Radiation: Involved Field Radiotherapy The prescribed dose
Next >>>